Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Effects of Cerebrolysin on Motor Recovery in Patients With Subacute Stroke
Phase 4
Completed
- Conditions
- Cerebrolysin
- Interventions
- Drug: porcine brain peptide (Cerebrolysin)Drug: Placebo
- First Posted Date
- 2013-11-27
- Last Posted Date
- 2016-05-11
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 71
- Registration Number
- NCT01996761
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy of Propafenone Versus Dronedarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation
- First Posted Date
- 2013-11-25
- Last Posted Date
- 2013-11-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 98
- Registration Number
- NCT01991119
- Locations
- 🇰🇷
Cardiac and Vascular Center, Seoul, Korea, Republic of
Change in Foveal Avascular Zone After Removal of Epiretinal Membrane and Internal Limiting Membrane
Not Applicable
- Conditions
- Epiretinal Membrane
- Interventions
- Procedure: epiretinal membrane and internal limiting membrane removal
- First Posted Date
- 2013-11-15
- Last Posted Date
- 2013-11-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT01985490
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma
Phase 2
Completed
- Conditions
- Primary Mediastinal Large B-cell LymphomaRelapsed or Refractory Hodgkin Lymphoma
- Interventions
- First Posted Date
- 2013-10-18
- Last Posted Date
- 2018-11-01
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT01965119
- Locations
- 🇰🇷
Wonju Severance Christian Hospital, Wonju, Korea, Republic of
🇰🇷Dong-A University, Busan, Korea, Republic of
🇰🇷Busan University Hospital, Busan, Korea, Republic of
Bortezomib Maintenance in High Risk DLBCL
- First Posted Date
- 2013-10-18
- Last Posted Date
- 2020-10-23
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 59
- Registration Number
- NCT01965977
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Ulcer in Bladder Pain Syndrome Patients
Completed
- Conditions
- Bladder Pain Syndrome
- Interventions
- Procedure: Transurethral Coagulation (TUC)Procedure: Transurethral Resection(TUR)
- First Posted Date
- 2013-10-17
- Last Posted Date
- 2017-12-14
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 126
- Registration Number
- NCT01963988
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Effectiveness of the Combined WLI and Hyperthermia for GI Cancer Liver Metastasis
Not Applicable
Terminated
- Conditions
- Hyperthermia
- Interventions
- Radiation: Combined hyperthermia and radiation therapy
- First Posted Date
- 2013-10-16
- Last Posted Date
- 2020-03-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 11
- Registration Number
- NCT01963117
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Zydena on Cognitive Function of Alzheimer's Disease Patients
Phase 3
- Conditions
- Alzheimer's Disease
- Interventions
- Drug: Placebo + Donepezil 5mg or 10mgDrug: Zydena (Udenafil) 100mg + Donepezil 5mg or 10mgDrug: Zydena (Udenafil) 50mg + Donepezil 5mg or 10mg
- First Posted Date
- 2013-09-12
- Last Posted Date
- 2013-09-12
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 210
- Registration Number
- NCT01940952
- Locations
- 🇰🇷
Samguns Medical Center, Seoul, Korea, Republic of
Patients Who Refractory Cancer Conqueror for Bio New Drug Development Translational Research Establishment
- Conditions
- Refractory Cancer
- First Posted Date
- 2013-08-30
- Last Posted Date
- 2013-08-30
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1523
- Registration Number
- NCT01932047
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gyunggido, Korea, Republic of
A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell Lymphoma
Early Phase 1
Completed
- Conditions
- Histologically Proven Extranodal NKTcell Lymphoma
- Interventions
- First Posted Date
- 2013-07-31
- Last Posted Date
- 2013-07-31
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 16
- Registration Number
- NCT01913119
- Locations
- 🇰🇷
Asan Medical Center, Songpa-gu, Seoul, Korea, Republic of
🇰🇷Severance Hospital, Seodaemun-gu, Seoul, Korea, Republic of
🇰🇷National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath